Abstract
Abstract only
- Title
- Etirinotecan pegol (EP, NKTR-102) in the treatment of high-grade glioma (HGG): A phase 2 trial
- Creators - without role
- Seema Nagpal - Cancer Prevention Institute of CaliforniaCathy Kahn Recht - Cancer Prevention Institute of CaliforniaUrooj Imtiaz - Cancer Prevention Institute of CaliforniaSophie Bertrand - Cancer Prevention Institute of CaliforniaReena Parada Thomas - Cancer Prevention Institute of CaliforniaAbdulrazag Ajlan - Cancer Prevention Institute of CaliforniaJustine Pena - Cancer Prevention Institute of CaliforniaMegan Gershon - Cancer Prevention Institute of CaliforniaPamela L. Kunz - Stanford UniversityGordon Li - Cancer Prevention Institute of CaliforniaLawrence David Recht - Cancer Prevention Institute of California
- Publication Details
- Journal of clinical oncology, Vol.32(15_suppl), pp.2096-2096
- Identifiers
- 9952992408331
- Academic Unit
- King Saud University
- Language
- English
- Resource Type
- Journal article